12/3
04:01 pm
tecx
Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024
Low
Report
Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024
11/26
04:01 pm
tecx
Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference
Low
Report
Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference
11/20
08:15 am
tecx
Tectonic Therapeutic (NASDAQ: TECX) is now covered by analysts at Raymond James. They set an "outperform" rating and a $65.00 price target on the stock.
Medium
Report
Tectonic Therapeutic (NASDAQ: TECX) is now covered by analysts at Raymond James. They set an "outperform" rating and a $65.00 price target on the stock.
11/13
02:07 am
tecx
Tectonic Therapeutic Inc. Reports Q3 2024 Results [Yahoo! Finance]
Low
Report
Tectonic Therapeutic Inc. Reports Q3 2024 Results [Yahoo! Finance]
11/12
09:43 am
tecx
Tectonic Therapeutic (NASDAQ: TECX) had its price target raised by analysts at Wells Fargo & Company from $55.00 to $79.00. They now have an "overweight" rating on the stock.
Medium
Report
Tectonic Therapeutic (NASDAQ: TECX) had its price target raised by analysts at Wells Fargo & Company from $55.00 to $79.00. They now have an "overweight" rating on the stock.
11/11
05:40 pm
tecx
Tectonic Therapeutic (NASDAQ: TECX) had its price target raised by analysts at Leerink Partners from $49.00 to $69.00. They now have an "outperform" rating on the stock.
Medium
Report
Tectonic Therapeutic (NASDAQ: TECX) had its price target raised by analysts at Leerink Partners from $49.00 to $69.00. They now have an "outperform" rating on the stock.
11/11
05:00 am
tecx
Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein
Low
Report
Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein
11/7
04:18 pm
tecx
Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
Medium
Report
Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
11/7
04:01 pm
tecx
Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights
Medium
Report
Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights
10/27
11:23 am
tecx
Tectonic Therapeutic Independent Director Acquires 7.0% More Stock [Yahoo! Finance]
Low
Report
Tectonic Therapeutic Independent Director Acquires 7.0% More Stock [Yahoo! Finance]
10/25
12:22 am
tecx
GPCR drugmaker Septerna amasses $288M in IPO [Yahoo! Finance]
Low
Report
GPCR drugmaker Septerna amasses $288M in IPO [Yahoo! Finance]
10/22
04:01 pm
tecx
Tectonic Therapeutic to Present Phase 1a Data at AHA 2024
Medium
Report
Tectonic Therapeutic to Present Phase 1a Data at AHA 2024
10/20
06:04 am
tecx
Tectonic Therapeutic: Interesting CV Disease Drug Developer [Seeking Alpha]
Low
Report
Tectonic Therapeutic: Interesting CV Disease Drug Developer [Seeking Alpha]